These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5868998)

  • 41. [Successful treatment of a severe afibrinogenemia by combined use of various antifibrinolytic substances].
    Wille P
    Geburtshilfe Frauenheilkd; 1965 Jul; 25(7):626-31. PubMed ID: 5297957
    [No Abstract]   [Full Text] [Related]  

  • 42. [Participation of adrenaline in the regulatory interaction of the coagulation and anti-coagulation systems].
    Kudriashov BA; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1972 Apr; 58(4):550-6. PubMed ID: 4623792
    [No Abstract]   [Full Text] [Related]  

  • 43. [Administration of epsilon-aminocaproic acid].
    Hrodek O
    Cesk Pediatr; 1968 May; 23(5):465-7. PubMed ID: 5660458
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of amino-methyl-cyclohexane-carboxylic acid (AMCHA) in activated hemostasis].
    Pfeifer GW; Dietz M
    Zentralbl Gynakol; 1969 Oct; 91(40):1292-5. PubMed ID: 5308573
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the effect of contrycal and epsilon-aminocaproic acid on anaphylactic guinea pigs].
    Sandow D; Keller HP
    Allerg Asthma (Leipz); 1967; 13(1):34-9. PubMed ID: 5582400
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolic and hemodynamic changes associated with the administration of epsilon amino caproic acid.
    Tice DA; Redisch W; Carroll HJ
    Surg Forum; 1965; 16():59-60. PubMed ID: 5835248
    [No Abstract]   [Full Text] [Related]  

  • 47. [Some pharmacological properties of epsilon-aminocaproic acid].
    Szurska H
    Ann Univ Mariae Curie Sklodowska Med; 1969; 24():203-14. PubMed ID: 5406028
    [No Abstract]   [Full Text] [Related]  

  • 48. [The hemostatic effect of 5-aminocaproic acid].
    Shvarsalon NS; Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(6):704-7. PubMed ID: 5876372
    [No Abstract]   [Full Text] [Related]  

  • 49. Preservation of vascular patency as a function of reticuloendothelial clearance.
    Gans H
    Surgery; 1966 Dec; 60(6):1216-23. PubMed ID: 5951295
    [No Abstract]   [Full Text] [Related]  

  • 50. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes of insulin-induced hypoglycemia in rats pretreated with reserpine or with epsilon-aminocaproic acid (EAC) or with epsilon-acetamido-caproic acid (EACA)].
    Agliati G; Conti F; Pelosi G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1824-7. PubMed ID: 5733081
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of epsilon-aminocaproic acid on wound healing.
    Rosen RG; LeVeen HH
    Surg Forum; 1966; 17():92-3. PubMed ID: 5921053
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the effect of epsilon-aminocaproic acid on anaphylactic shock in guinea pigs].
    Tchórzewski H
    Acta Physiol Pol; 1966; 17(1):89-94. PubMed ID: 5917800
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of epsilon-aminocaproic acid on the normalization of embolizing fatty matter in the rabbit lung following experimental fractures. A polarized light study].
    Modugno P
    Arch Sci Med (Torino); 1983; 140(2):159-64. PubMed ID: 6882191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The value of epsilon aminocaproic acid in the dental practice].
    Deydier C; Masson CL
    Inf Dent; 1969 Jul; 51(27):2803-5. PubMed ID: 5254398
    [No Abstract]   [Full Text] [Related]  

  • 56. [Inhibition of proteolytic activity by administration of epsilon-aminocaproic acid for the protection of skin homografts].
    Oprişiu C; Doroga H; Danciu F
    Stomatologia (Bucur); 1966; 13(3):221-4. PubMed ID: 5224149
    [No Abstract]   [Full Text] [Related]  

  • 57. [Properties of a new drug: epsilon aminocaproic acid].
    Prezioso M
    Friuli Med; 1967; 22(2):445-51. PubMed ID: 5607706
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative effectiveness of epsilon-aminocaproic acid and contrical in preventing complement activation on immune complexes].
    Tsibul'kin AP; Raĭzman SM
    Farmakol Toksikol; 1981; 44(3):316-9. PubMed ID: 6169545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro fibrinolysis of the buffer coat coagulum].
    Harms D; Schmalisch N
    Frankf Z Pathol; 1966; 75(2):148-57. PubMed ID: 5995081
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis and activity of N alpha-(epsilon-aminocaproyl)-alanines and N epsilon-(epsilon-aminocaproyl)-caproic acid.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1995; 52(6):505-7. PubMed ID: 8960269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.